HTA136 Impact on Scottish Medicines Consortium Reimbursement Decisions When Assessed Under the Orphan Drug Process

Abstract

Authors

P Sharma A Mandal K Mark R Melchior

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×